PHAR’s research was well represented at ISPOR’s annual meeting with six posters total. PHAR presented a self-funded study describing an adaptation of the RAND/UCLA Delphi panel method for virtual use. PHAR’s outcomes research team also presented a systematic literature review assessing the value of next-generation sequencing in advanced cancer, and a validated claims algorithm to identify patients with severe hemophilia A. PHAR’s real world evidence team presented three secondary data analysis studies, which summarized the burden associated with misdiagnosing neuromyelitis optica spectrum disorders, measured healthcare utilization and costs of diagnosing AL amyloidosis in the inpatient setting, and described treatment patterns in newly treated patients with Parkinson’s disease. All of these posters can be found on the PHAR publications page, and accompanying abstracts will be published in the ISPOR supplement of Value in Health.